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Spatial Variability of the 12-Lead Surface ECG as a
Tool for Noninvasive Prediction of Catheter
Ablation Outcome in Persistent Atrial Fibrillation
Marianna Meo1, Student Member, IEEE, Vicente Zarzoso1, Senior Member, IEEE, Olivier Meste1, Member, IEEE,
Decebal Gabriel Latcu2, and Nadir Saoudi2
Abstract—Atrial fibrillation (AF) is the most common sus-
tained cardiac arrhythmia encountered in clinical practice. Ra-
diofrequency catheter ablation (CA) is increasingly employed to
treat this disease, yet selection of persistent AF patients who
will benefit from this treatment remains a challenging task.
Several parameters of the surface electrocardiogram (ECG) have
been analyzed in previous works to predict AF termination by
CA, such as fibrillatory wave (f-wave) amplitude. However, they
are usually manually computed and only a subset of electrodes
is inspected. In the present study, a novel perspective of the
role of f-wave amplitude as a potential non-invasive predictor
of CA outcome is adopted by exploring ECG inter-lead spatial
variability. An automatic procedure for atrial amplitude compu-
tation based on cubic Hermite interpolation is first proposed. To
describe the global f-wave peak-to-peak amplitude distribution,
signal contributions from multiple leads are then combined
by condensing the most representative features of the atrial
signal in a reduced-rank approximation based on principal
component analysis (PCA). We show that exploiting ECG spatial
diversity by means of this PCA-based multilead approach does
not only increase the robustness to electrode selection, but also
substantially improves the predictive power of the amplitude
parameter.
Index Terms—Atrial fibrillation (AF), catheter ablation (CA),
principal component analysis (PCA), fibrillatory wave (f-wave).
I. INTRODUCTION
D
espite major advances in its treatment, atrial fibrilla-
tion (AF) remains a significant cause of cardiovascular
morbidity and mortality, especially those arising from stroke
and heart failure. AF is characterized by uncoordinated atrial
activation with consequent loss of atrial mechanical function.
Various therapies have been used, such as electrical cardiover-
sion, antiarrhythmic drugs and catheter ablation (CA) tech-
niques. However, current AF management guidelines provide
no systematic treatment recommendations, since the various
mechanisms and patterns of this disease are not completely
understood yet [1]. The CA therapy has been increasingly
Manuscript received April 18, 2012; revised July 12, 2012, and accepted
August 20, 2012. This work is partly supported by the French National
Research Agency under contract ANR-2010-JCJC-0303-01 ”PERSIST”. Mar-
ianna Meo is funded by a doctoral grant from the French Ministry of Higher
Education and Research.
1Marianna Meo, Vicente Zarzoso and Olivier Meste are with the Lab-
oratoire d’Informatique, Signaux et Systèmes de Sophia Antipolis (I3S),
Université Nice Sophia Antipolis, CNRS, France (e-mail:{meo, zarzoso,
meste}@i3s.unice.fr).
2Decebal G. Latcu and Nadir Saoudi are with the Service de Car-
diologie, Centre Hospitalier Princesse Grace, Monaco (e-mail: {dg.latcu,
nsaoudi}@chpg.mc).
used as a first-line option in recent years [2]. Nowadays,
the stepwise technique is the most widespread. It consists
in a sequence of actions aiming at suppressing the sources
of abnormal rhythm by radiofrequency cauterization, typically
including pulmonary vein (PV) isolation with an endpoint of
lasso-proven disconnection [3], [4] and ablation of complex
fractionated atrial electrograms (CFAE) [5]. However, CA
of persistent AF is a lengthy and expensive procedure, and
inconsistent success rates have been reported by different
centers practicing the therapy. Consequently, this has called
for adequate tools exploiting information about AF electro-
physiology to perform an a priori selection of patients who
are more likely to positively respond to CA therapy.
AF analysis by means of non-invasive ECG recordings
has received considerable attention in recent years, spurring
the development of signal processing techniques for a more
advanced characterization of the atrial waveforms. So far, the
cycle length or inverse dominant frequency (repetition rate)
of the atrial waves is one of the most studied parameters.
Its clinical significance is founded on its ability to iden-
tify pathophysiological mechanisms and predict therapy effi-
cacy [6]. Other studies [7] underline that higher pre-procedural
values of the amplitude of the fibrillatory waves (f-waves)
can be associated with a higher probability of successful
procedures. Nevertheless, several limitations affect the dis-
criminative power of such classifiers. First and foremost, their
manual acquisition considerably increases error probability, as
it is influenced by operator’s subjectivity. Furthermore, the
single-lead perspective neglects potentially useful information
from other leads. Yet considering multiple leads may help shed
some light on the disease by analyzing the heart electrical
activity from different spatial locations.
In this framework, our research aims at the noninvasive pre-
diction of CA outcome by characterizing the f-wave amplitude
variability across the multiple leads of the ECG. An automatic
algorithm for computing atrial amplitude on a single lead is
first proposed. F-wave amplitude is quantified by interpolating
local extrema points of the actual signal. This procedure repre-
sents the starting point of a multilead algorithm, which yields
a parameter describing f-wave amplitude spatial distribution
over the eight independent ECG leads by applying principal
component analysis (PCA). Our investigation demonstrates the
benefits of exploiting ECG spatial diversity, which enhances
the f-wave amplitude discriminative power and improves its
robustness to electrode selection in CA outcome prediction.
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II. METHODS
A. ECG Data and Acquisition System
The 28 patients involved in this study were all affected
by persistent AF and underwent CA. They all gave their
informed consent. The procedure was performed with the aid
of Prucka Cardiolab and Biosense CARTO electrophysiology
measurement systems at the Cardiology Department, Princess
Grace Hospital, Monaco. For each patient, one-minute 12-
lead surface ECG was recorded at a sampling rate of 1 kHz
at the beginning of the ablation procedure. An example on
lead V1 is illustrated in Fig. 1. Ablation was performed in a
stepwise manner [2], starting with circumferential PV ablation
with LASSO-guided disconnection, followed by fragmented
potentials, non-PV triggers, roof line and mitral isthmus line
right atrial ablation.
The present study adopts a short-term definition of procedu-
ral outcome, providing a preliminary perspective of immediate
CA effectiveness and examining the risk of AF recurrence
in the very first postoperative period. Short-term success is
defined as AF conversion either directly to sinus rhythm or
intermediate tachyarrhythmia, exclusively by ablation or by
CA followed by electrical cardioversion. Three patients who
did not experience AF termination after a first procedure
underwent a second ablation, making a total of nP = 31
procedures. Accordingly, nS = 26 procedures were successful,
whereas nF = 5 procedures failed.
B. ECG Preprocessing and Atrial Activity Extraction
The preprocessing steps described in the sequel are moti-
vated by our interest in examining f-wave amplitude prop-
erties, regardless of their temporal location or shape fac-
tors. Indeed, focusing on amplitude parameters allows us
to avoid frequency-based methods requiring atrial activity
(AA) extraction, widely regarded as a not trivial task, thus
considerably simplifying our approach. Our strategy also
avoids straightforward analysis of ECG morphology, which is
reasonable to apply when dealing with f-waves whose shape
is very repetitive and easy to segment; this is typically not
the case in more advanced forms of the disease such as the
persistent AF examined in the present study. Moreover, f-
wave amplitude predictive power is widely recognized in the
framework of persistent AF ablation, as it represents the sum
of local depolarization phenomena involving cardiac cells [7].
Its examination proves to be easier to perform and equally
efficient compared to morphology-based analysis, requiring
more complex heart models [8], [9]. Finally, to our knowledge,
no correlation between f-wave morphology and CA outcome
has been shown to date.
Accordingly, ECG recordings are first processed by a fourth-
order zero-phase type II Chebyshev bandpass filter with −3
dB attenuation at 0.5 Hz and 30 Hz cut-off frequencies. The
filter selected can accurately reduce the influence of noisy
components typically encountered in ECG analysis without
deforming signal shape [10], [11]. The choice of pass-band
is meant to exclusively enhance AF content, whose dominant
frequency ranges between 3 and 12 Hz, by suppressing base-
line wandering and high frequency noise such as myoelectric
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Fig. 1: Example of ECG recording during AF and its characteristic
waves. Boxes highlight TQ intervals which are concatenated to form
the AA signal YAA in eqn. (1).
artifacts and 50 Hz power line interference. Automatic detec-
tion of ECG fiducial points is subsequently performed so as
to properly segment the TQ intervals. R wave time instants
are retrieved on lead V1 by applying the Pan-Tompkins’
algorithm [12], whereas Q wave onset and T wave offset are
detected with an improved version of Woody’s method [13].
Mean-centering and concatenation of such segments are finally
accomplished, thereby yielding an (L×N) data matrix YAA
representing atrial activity (AA) only:
YAA = [yAA(1) · · ·yAA(N)] ∈ R
L×N (1)
where vector yAA(n) = [y1(n), . . . , yL(n)]
T stands for the
multilead AA signal at sample index n, L is the number of
leads used, and N the number of samples of the AA signal
yℓ(n) for each lead ℓ = 1, 2, . . . , L. All residual artifacts and
spurious peaks due to concatenation have been automatically
removed by means of signal first-derivative thresholding.
Unlike previous works, a subset of all leads of the standard
ECG has been used in our algorithms. Indeed, Einthoven’s
standard leads (or limb leads, I, II, III) and Golbderger’s
augmented leads (aVR, aVL, aVF) are derived from the same
three measurement points, and are thus redundant (linearly
related) [2]. Accordingly, lead III has been discarded by
our analysis, as I and II are sufficient to characterize heart
electrical activity on the frontal plane. Finally, all precordial
leads have been introduced too, in order to record the cardiac
electric potential in a cross sectional plane, for a total of L=8
leads, that is, I, II, V1-V6.
C. Automatic F-wave Amplitude Computation
According to previous studies, successful CA procedures
can be predicted by higher values of f-wave peak-to-peak
amplitude on the surface ECG [7]. Nevertheless, prediction
accuracy is so far affected by amplitude manual computation,
leading to higher error probability, especially in the pres-
ence of irregular and complex waveform patterns. Similar
shortcomings can occur when dealing with different operators
performing the acquisition of such a parameter, so its measure
is not uniquely defined. Given these conditions, we develop
an automatic procedure which computes the amplitude value
of the AA signal yℓ(n) on a specific lead ℓ = 1, 2, . . . , L. It
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Fig. 2: Single-lead atrial waveform interpolation algorithm. Upper
and lower envelopes eMAX and eMIN pass through the local extrema
of the input signal yℓ; their subtraction yields eDIFF.
starts from the detection of the local maxima of yℓ(n) and
the estimation of an upper envelope eMAX(n) by the shape-
preserving piecewise cubic Hermite interpolating polynomial
(PCHIP) [14]. Similarly, a lower envelope eMIN(n) passing
through the minima is obtained as well. This strategy of auto-
matic detection of local extrema of the f-waves proves more
efficient than the manual approach, as it mainly focuses on
the global trend of the curve. In addition, PCHIP interpolation
reduces the negative effect of local spurious peaks and signal
artifacts. Peaks located near the edge between two consecutive
TQ intervals are not taken into account in the interpolation.
The difference eDIFF(n) = |eMAX(n) − eMIN(n)| between
the two curves outlines the general trend of the main oscilla-
tions of f-waves, and its temporal mean over the AA signal
length N :
D(y) =
1
N
N∑
n=1
eDIFF(n) (2)
represents the final output of our algorithm. The operator D(·)
is characterized by an offset-invariance property:
D(ky + α) = |k|D(y), ∀k, α ∈ R. (3)
Index D is capable of summarizing the information about f-
wave over the whole recording and its peak-to-peak amplitude
pattern in a single objective parameter computed in a fully
automated manner.
D. Extension to Multilead Recordings
A further limitation of previous methods is that f-wave
amplitude is examined on individual leads only (e.g., V1 or
II) [7], without fully exploiting the spatial diversity typical
of multilead ECG recordings. It is widely known that the
largest atrial-to-ventricular amplitude ratio can be found on
lead V1 [15]. Yet its proximity to the right atrial free wall may
neglect significant information about other sites, for instance,
the left atrium and the PVs, which play a crucial role in
AF initiation and maintenance [3]. Indeed, not only these
approaches do not rely on contributions provided by other
ECG leads and their mutual relations, but selection of single
electrodes is not driven by further systematic criteria.
These conditions represent the basis for the development
of an extension of the algorithm described in Sec. II-C so as
to broaden single-lead characterization of f-wave amplitude
by considering more than one lead. The rationale of our
hypothesis is the intrinsic variability of the surface ECG across
leads, as they are all measured from different points of the
patient’s body. Our multivariate AA signal can be regarded as a
surface mixture of a certain number of unknown sources. This
assumption motivates the application of principal component
analysis (PCA). PCA can express our multilead recordings as
a function of these uncorrelated, most representative sources,
or principal components (PCs) [16], by retaining the maximum
amount of information as measured by variance. PCs are
computed and ordered so that the first few retain most of the
variation present in all of the original signals. Since variance
and amplitude are closely related, the most dominant PCs
are expected to provide an accurate description of the spatial
distribution of AA amplitude.
According to PCA, our multivariate observation ma-
trix YAA can be decomposed as the linear model:
yAA(n) = Mx(n) =
L∑
k=1
mkxk(n) (4)
where M is the mixing matrix with mutually orthogonal
columns that relates the sources xk(n), k = 1, . . . , L with
the multilead observations yAA(n). The derivation of PCs
is based on the assumption that yAA(n) is a zero-mean
random process. The entries of column vector mk weigh
the contribution of the corresponding PC xk to the leads in
yAA(n), and thus render the principal propagation direction
or spatial topography of each source [17]. This decomposition
effectively exploits spatial relationships among ECG leads
and discards redundant information by keeping only the most
significant PCs and their corresponding directions.
E. Reduced-Rank PCA for Atrial Signal Characterization
Knowing that the dominant PC retains the highest percent-
age of the AA signal variance, it seems reasonable to attempt
the exploitation of this property to extract the most significant
information from the AA signal. It is worth introducing the
general concept of spatial filtering, as an optimal tool for
recovering a certain signal of interest from the ensemble of
observations [18]. In the PCA framework, the idea is to look
for a linear function of the elements of yAA having maximum
variance. In line with this rationale, the spatial filter m1 is the
linear weight vector yielding the dominant PC x1 as
x1(n) = m
T
1 yAA(n), (5)
thus isolating the contribution of x1 to yAA from that coming
from other sources. The first principal direction m1 maximizes
the variance of x1, given by E[x
2
1] = m
T
1 Rym1, under the
constraint ‖m1‖ = 1, where Ry denotes the covariance matrix
of the observations. The maximal variance is achieved when
m1 is the normalized dominant eigenvector (related to the
highest eigenvalue) of Ry. The output function in eqn. (5) can
clearly be seen as a weighted average of the observed random
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variables. The remaining principal directions are also esti-
mated by variance maximization, but including orthogonality
constraints with respect to the previously obtained directions.
The truncation of eqn. (4) yields the rank-R approximation:
yˆAA(n) =
R∑
k=1
mkxk(n) (6)
with R < L. Note that yˆAA has the same size as yAA. In
this work, we propose to approximate the AA observations
by exclusively emphasizing the influence of the first PC on
the selected leads; this is achieved with R = 1 in eqn. (6).
This rank-1 reconstruction allows not only the enhancement
of the most descriptive component in terms of variance but,
as shown in Sec. III, also the suppression of irrelevant and/or
noisy elements which can pollute signal content.
F. Multilead F-wave Amplitude Descriptor
Once AA signal approximation is carried out, the algorithm
presented in Sec. II-C is run on each lead. Unlike eqn. (2),
which returns a scalar value as output, we obtain now an L-
component vector DL, whose entries represent the temporal
average of peak-to-peak amplitude envelope values on every
electrode:
DL = [d1, d2, . . . , dL]
T. (7)
where dℓ = D(mℓ1x1) =|mℓ1|D(x1), according to the
property in eqn. (3), and mℓ1 = [m1]ℓ is the ℓth component
of the principal direction m1. The entries of DL are then
sorted in increasing order and their median value D˜L is finally
obtained. The choice of the median is justified by its ability
to describe overall data distribution without loss of generality,
with a higher degree of robustness to outliers, compared to
other statistical descriptors such as the mean value. Parameter
D˜L can be considered as a descriptor of the global spatial
distribution of f-wave amplitudes over the observed leads.
G. Statistical Analysis
According to the protocol explained in Sec. II-A, ablation
outcome categories to be discriminated are referred to as “AF
termination” and “non AF termination” by CA. All parameters
are expressed as mean ± standard deviation in Table I. Once
data Gaussianity has been verified through the Lilliefors’ test,
differences between the two classes are statistically assessed
by an unpaired Student’s t-test if data follow a normal distri-
bution, a two-sample Wilcoxon rank sum test otherwise, under
a confidence level α=0.05; p values associated with each
unpaired test are reported in Table I as well. The quality of
the binary classification model is measured by the area under
curve (AUC) of its receiver operating characteristic (ROC)
curve, based on the maximization of sensitivity and specificity,
i.e., the rate of true positives and true negatives, respectively.
A leave-one-out (LOO) cross-validation technique is employed
to assess the generalization ability of our analysis to an inde-
pendent dataset. More specifically, AUC values are computed
several times by keeping a sample of 30 procedures out of
31 and thus discarding one subject at each iteration, so as to
compute their average value at the final step. AUC values of
TABLE I: Interclass statistical analysis
AF Non AF
p-value
termination termination
D˜8 0.038 ± 0.019 0.015 ± 0.007 9.56 · 10−4
D˜12 0.030 ± 0.012 0.015 ± 0.006 8 · 10−3
D8 0.042 ± 0.023 0.022 ± 0.01 6.4 · 10−2
D12 0.049 ± 0.070 0.022 ± 0.01 5.0 · 10−2
D(V1) 0.068 ± 0.022 0.054 ± 0.017 1.85 · 10−1
RMS(V1) 0.075 ± 0.110 0.027 ± 0.017 1.55 · 10−1
SampEn(Ls, r
(1)
s ) 0.299 ± 0.063 0.218 ± 0.107 2.67 · 10
−1
SampEn(Ls, r
(2)
s ) 0.143 ± 0.029 0.106 ± 0.052 3.25 · 10
−1
R˜MS8 0.016 ± 0.009 0.009 ± 0.006 1.40 · 10−1
R˜MS12 0.024 ± 0.015 0.016 ± 0.008 1.40 · 10−1
RMS8 0.021 ± 0.016 0.021 ± 0.021 3.76 · 10−1
RMS12 0.037 ± 0.048 0.026 ± 0.024 2.48 · 10−1
each descriptor are displayed in Table II; in addition, we report
the corresponding optimal cut-off points, associated with the
maximization of the sum of true positive and true negative
cases determined over the 31-procedure database.
III. RESULTS
To test the single-lead algorithm presented in Sec. II-C,
parameter D in eqn. (2) has been computed on lead V1, yield-
ing D(V1). Another classical single-lead method focusing on
AA signal magnitude has been considered for the sake of
comparison, namely, the root mean square value on the lead
V1, denoted RMS(V1). Finally, a parallel with a non-linear
complexity index, the sample entropy SampEn [19], has been
drawn as well on the same electrode. This feature depends on
two parameters: Ls and rs. Parameter Ls stands for the length
of the sequences the ECG recording is split in. Such sequences
are then compared, and the tolerance for accepting matches is
represented by the parameter rs. This parameter is chosen as
a fraction of the AA input signal standard deviation on V1,
denoted σV1 , so as to assure the translation and scale invariance
of SampEn. Both parameters have been tuned according to the
guidelines given in [20], yielding Ls = 2 besides two values
of rs, namely, r
(1)
s = 0.1σV1 and r
(2)
s = 0.2σV1 .
In the multilead framework, the discriminative power of
our descriptor D˜L has been assessed both on the ensemble
of eight linearly independent ECG leads (L = 8), as defined
in Sec. II-A, and on the full standard ECG (L = 12), giving
rise to indices D˜8 and D˜12, respectively. The same analysis
has been led by using the mean instead of the median when
averaging the entries of vector DL in eqn. (7), yielding D8
and D12. This is the index proposed in [21], but using PCHIP
instead of cubic spline interpolation. Finally, the ability of
PCHIP interpolation to effectively approximate the AA signal
general trend and give a measure of f-wave peak-to-peak
amplitude is also examined. For sake of comparison with
our algorithm, after PCA application and rank-1 truncation
explained in Sec. II-E, the RMS value is computed on every
row of the data matrix YˆAA resulting from eqn. (6). Both sets
of ECG leads have been considered for the computation of
this feature as well, from which the median (R˜MS8, R˜MS12)
and mean values (RMS8, RMS12) have been determined.
Robustness of our multilead predictor D˜L to the choice of
ECG leads has also been tested. For each value of lead-subset
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TABLE II: CA outcome prediction performance
AUC Best cut-off
D˜8 0.98 0.023
D˜12 0.91 0.022
D8 0.77 0.027
D12 0.78 0.027
D(V1) 0.68 0.060
RMS(V1) 0.71 0.013
SampEn(Ls, r
(1)
s ) 0.75 0.289
SampEn(Ls, r
(2)
s ) 0.72 0.139
R˜MS8 0.72 0.005
R˜MS12 0.72 0.011
RMS8 0.63 0.012
RMS12 0.67 0.014
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Fig. 3: D˜L prediction performance as a function of the size L of the
subset of the 8 independent ECG leads. Vertical lines stretch between
the minimum and maximum AUC values obtained for each L; mean
values are shown with markers. AA: measuring D˜L directly from the
observed AA signal. PCA: measuring D˜L from approximation (6)
with R = 1.
size L ranging from 1 up to 8, the proposed multilead predictor
has been run on all 8!/((8−L)!L!) possible lead combinations.
CA outcome prediction performance has then been assessed
for each lead combination from the corresponding values of
D˜L, using the LOO technique. In this manner, the minimum,
maximum and mean AUC values over all L-lead subset
combinations have been obtained as a function of the subset
dimension L; their corresponding intervals are displayed in
Fig. 3. The lead combinations providing the best prediction
performance for each subset dimension are shown in Table III.
Likewise, the straightforward application of the algorithm
described in Sec. II-C on the AA signal (namely, without
PCA approximation) has been tested, in order to demonstrate
PCA effectiveness in filtering and enhancing content-bearing
information from the AA signal. Along the same lines, PCA’s
ability to compress data into few, most representative PCs is
shown in Fig. 4, in which approximation quality is assessed
by the AUC criterion; classification performance over all ECG
leads is evaluated as a function of R, the number of terms
retained in the truncation in eqn. (6), ranging from 1 (the
value adopted in our algorithm) to 8 (full-rank reconstruction
of the input data). This comparison is validated by the LOO
procedure.
TABLE III: ECG lead subsets with optimal prediction performance
based on parameter D˜L
Number of leads (L) Leads
1 V3
2 II, V4
3 I, V3, V4
4 II, V3, V4, V5
5 II, V1, V3, V5, V6
6
[I, II, V1, V3, V5, V6]
[I, II, V2, V4, V5, V6]
[II, V1, V2, V4, V5, V6]
7
[I, II, V1, V2, V4, V5, V6]
[II, V1, V2, V3, V4, V5, V6]
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Fig. 4: Classification performance for the 8 linearly independent
ECG leads. AUC of D˜8 as a function of R, the number of PCs
retained in approximation (6).
IV. DISCUSSION
A. Manual vs. Automatic Computation of Atrial Amplitude
The predictive value of f-wave amplitude for CA of persis-
tent AF has been scrutinized in previous studies [7]. However,
not only it has been manually obtained, but only one ECG
lead has been considered in its computation. By contrast, a
method aiming at automatically computing f-wave peak-to-
peak amplitude on a single lead is proposed in our study
(Sec. II-C). Direct correlation with procedural AF termination,
as demonstrated in [7] for the manual amplitude index, is
confirmed for its automatic counterpart proposed herein. This
is shown by the results of the single-lead parameters in Table I,
namely D(V1) and RMS(V1). However, the low p values
obtained with these indices prove their weak discriminating
ability in the dataset under examination.
From the analysis of f-wave peak-to-peak amplitude it can
be inferred that our single-lead automatic approach, yielding
D(V1), returns values close to those manually computed in [7]
(0.08±0.03 mV for successful CA procedures, 0.05±0.03 mV
for the failing ones, p < 0.01, AUC = 0.77). This com-
parison only aims at underlining the ability of our procedure
to automatically reproduce such results and associate higher
amplitude values with successful CA procedures, event though
the respective databases are not directly comparable and
interclass statistically significant differences are not verified
on the signals we examined.
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B. Comparison with Other Atrial Signal Parameters
Another parameter considered in our investigation is the
RMS value, whose prediction performance proves rather inac-
curate. Furthermore, the unpaired test returns non-significant
differences between the classes considered. Concerning the
sample entropy SampEn, despite the fairly good AUC values
and the presence of statistically significant differences between
the categories of interest, AF termination by CA is not
predicted by low SampEn values as in [22] for electrical
cardioversion. This is in contrast with the assumption of
a positive correlation between the sample entropy and AA
signal spatio-temporal complexity. One would actually expect
that more organized AA waveforms as measured by lower
SampEn values render a less critical disease profile, easier
to be treated by CA. Yet this hypothesis is not verified in
our study, regardless of the threshold rs chosen. Finally, not
only the computational load demanded by SampEn is notably
higher than that of other predictors, but it is also sensitive to
the tuning parameters defined above, so their incorrect setting
can lead to results that are quite disparate and not easy to
interpret. Generally speaking, all the single-lead descriptors
(D(V1), RMS(V1), SampEn(Ls, r
(1)
s ), SampEn(Ls, r
(2)
s ))
exhibit weak discriminating capabilities, as confirmed in Ta-
ble II by their low AUC values.
C. Multilead Atrial Signal Amplitude Measurement
The present work has also developed an automatic system
of acquisition of the value of the atrial amplitude exploiting
information derived from the intrinsic spatial diversity of the
multilead ECG (Secs. II-D–II-F). Regarding this multilead
perspective, traditional features based on RMS values com-
puted on several leads seem no to be able to characterize f-
wave amplitude content. Indeed, descriptors derived from the
combination of such values cannot depict significant interclass
differences, and AUC values in Table II are quite weak
too, especially those related to the prediction performance of
RMS8 and RMS12. By contrast, descriptors defined in our
PCA-based multilead framework are more robust and reliable
than their single-lead counterparts and than classical multilead
approaches. The novel predictor D˜8 succeeds in pointing out
significant differences between the two classes of interest,
as shown in Table I, which are in keeping with evidence
about the predictive power of f-wave amplitude [7]. What is
more, CA outcome prediction performance is enhanced by the
appropriate use of more than one ECG lead, as we can see in
Table II. In Fig. 3 the predictive power of D˜L is quantified by
the AUC criterion, expressed as a function of the number of
ECG leads. The benefits of examining more than one lead are
clearly evidenced by the increasing trend of the mean AUC as
more leads are progressively introduced into the analysis.
D. Benefits of PCA-based ECG Signal Approximation
The second advantage of our multilead approach also per-
tains to the application of PCA, when compared with the
direct examination of AA signal amplitude. From Fig. 3,
PCA superiority over the straight computation of f-wave
amplitude on the AA signal can be inferred. Indeed, AUC
mean values are generally higher than those obtained without
PCA preprocessing. In addition, the higher the number of
leads, the larger the difference between the two methods, as
AUC ranges partially or completely overlap only when L
is sufficiently low. Similar conclusions can be drawn from
Fig. 4 when examining AUC evolution as a function of the
quality of approximation (6). The fewer PCs used in the
approximation, the better the prediction performance. PCA
typically assigns noisy and/or spurious signal components to
the least significant PCs, which seems to enable the extraction
of the most meaningful information about atrial amplitude
when retaining the dominant PC of the atrial ECG data.
E. ECG-lead Preselection
This consideration is in line with the increased accuracy in
CA outcome prediction when exploiting 8 leads rather than the
whole standard ECG. It is commonly acknowledged that over
90% of the heart’s electric activity in physiological conditions
can be explained with a dipole source model, whose evaluation
can be assessed by measuring its 3 independent compo-
nents [23]. In principle, two of the limb leads could reflect the
frontal plane components, whereas one precordial lead could
be chosen for the anterior-posterior contribution. Accordingly,
their combination should provide a complete knowledge about
the electric heart vector. However, the assumption of a fixed-
location single dipole could be overly simplistic under AF. In
fact, the distributed properties of cardiac sources and the effect
of the thoracic surface and internal inhomogeneities should
also be included in our model. In addition, the precordial leads
detect further nondipolar components which are located on the
heart frontal plane and have high diagnostic significance [23].
The use of all 12 leads in standard clinical practice is justified
by the fact that clinicians can compare the projections of the
resultant vectors in 2 orthogonal planes and at different angles,
improving pattern recognition. Nevertheless, in our research
framework, preselecting the subset of 8 linearly independent
leads seems to boost PCA filtering action, as redundant and/or
polluting elements are already partially removed before the
decomposition, and the most essential and meaningful com-
ponents are put into evidence more easily. This may explain
why D˜8 outperforms its 12-lead equivalent.
F. Multilead Atrial Amplitude Computation Modalities
Further attention should be given to the computation modal-
ities of the multilead descriptor of f-wave amplitude, e.g.,
how contributions coming from the ECG leads employed are
combined with each other. In [21], the mean value of the
entries of DL in eqn. (7) was employed as a predictor (using a
different interpolation technique). In this paper, we present an
improved version of this algorithm, where the mean is replaced
with the median. Both approaches have the common objective
of looking for the measure of central tendency of the dataset;
roughly speaking, the most recurrent element which can sum-
marize the average information intrinsic to the dataset itself.
Experimental evidence reveals that the median value statistic
(˜·) performs better than the mean (·) on our signal database,
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since it is less sensitive to outliers, as mentioned above.
Furthermore, the median is more suitable for skewed data
distributions, this being often the case of f-wave amplitude,
whose visibility and magnitude can depend on lead location. In
the light of these considerations, we can interpret CA outcome
prediction performance of the features D12 and D8: interclass
differences are poorly significant or not significant, so that
results presented in [21] do not seem to generalize to the
larger dataset used in this work. Finally, the mean value DL
indistinctly takes contributions from all leads into account. On
the contrary, the median D˜L exclusively highlights the role
played by certain leads in the description of the global trend of
f-wave amplitude, while neglecting the extrema of DL, which
are generally not representative enough to summarize the main
characteristics of this spatial distribution.
G. Lead Subset Selection for Optimal Prediction Performance
Another interesting result concerns the subsets of leads
yielding optimal classification performance based on atrial
signal amplitude measures. Table III shows that some lead
combinations recur in each subset. In particular, the optimal L-
lead subset typically includes leads of smaller optimal subsets,
together with a new electrode. The presence of leads represent-
ing heart electrical activity on multiple planes confirms again
the hypothesis that clinical information coming from multiple
electrode locations can improve ablation outcome prediction.
We can also observe that lead V1 only starts being significant
from L = 5, in contrast with standard medical practice for
AF analysis where V1 is usually the lead of choice [15]. This
result can probably be due to the fact that this lead is not
close enough to the PVs and the left atrium, thus neglecting
significant information from these atrial areas deeply involved
in AF triggering and maintenance.
H. Limitations of the Study
Our research is hampered by the lack of comparison with
endocardial recordings. Multilead surface ECG provides a
global overview of heart activity, whereas endocardial sig-
nals account for local information. Nevertheless, since we
aim at a noninvasive analysis, endocardial recordings were
not contemplated in the present study. The superiority of
our atrial amplitude measure over conventional CA outcome
predictors has been demonstrated. However, its performance
in the presence of noise and interference not suppressed by
the preprocessing filter remains to be investigated in more
detail. Finally, database evaluation is also affected by several
confounding factors, e.g., cardioversion and/or drugs, although
procedural AF termination by CA is not predictive of long-
term outcome [24].
V. CONCLUSIONS
This work has proposed a novel procedure for computing
f-wave peak-to-peak amplitude to predict short-term CA out-
come in persistent AF patients. Our single-lead automatic pro-
cedure is based on PCHIP interpolation, and yields numerical
results comparable to those reported in previous works [7]
while avoiding the shortcomings of manual measures We have
also developed an automatic system of acquisition of the atrial
amplitude in the multilead ECG based on PCA, which tries to
capture and exploit the intrinsic variability of the atrial signal
across different leads. The proposed PCA approximation to
the multilead atrial signal extracts the most relevant compo-
nents describing f-wave magnitude spatial distribution over the
selected ECG leads. Followed by interpolation and averaging,
the algorithm condenses the multilead atrial amplitude into
a single descriptor. Results on a database of persistent AF
ECGs recorded before ablation have confirmed the ability
of this f-wave amplitude descriptor to carry out short-term
CA outcome prediction. The proposed multilead approach
outperforms single-lead techniques and shows an increased
robustness to electrode selection, making it particularly useful
in scenarios where some leads do not provide an effective
contribution to the recording, e.g., if they get accidentally loose
or disconnected from the patient’s skin. Further benefits are
derived from PCA’s data compression capabilities, as signal
approximations with decreasing rank progressively improve
classification performance by retaining the most descriptive
components of the observations while filtering out pollut-
ing contributions. We can conclude that the spatio-temporal
properties of the surface ECG can quantitatively assess the
impact of CA over fibrillatory activity typical of persistent
AF and improve patient selection. Multilead processing of the
ECG offers deeper insights into the AA waveform pattern and
AF pathophysiology than single-lead methods, as our analysis
shows in the context of CA outcome prediction.
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